Malaria & Lariam (mefloquine) – latest guidelines

  Summary of information received from MHRA – Medicines & Healthcare Products Regulatory Authority. Although the risk of neuropsychiatric side effects with mefloquine (Lariam) is well-established, a recent review of the prescribing information has led to strengthened warnings and new … Continued